HB Fuller (NYSE:FUL) Price Target Cut to $46.00 by Analysts at JPMorgan Chase & Co.

HB Fuller (NYSE:FUL) had its target price lowered by analysts at JPMorgan Chase & Co. from $51.00 to $46.00 in a research report issued on Friday, June 28th, Stock Target Advisor reports. The firm presently has a “neutral” rating on the specialty chemicals company’s stock. JPMorgan Chase & Co.‘s price target points to a potential downside of 4.09% from the stock’s previous close.

Other equities research analysts also recently issued research reports about the company. ValuEngine downgraded Wolverine World Wide from a “hold” rating to a “sell” rating in a research report on Monday, May 20th. TheStreet downgraded TIM Participacoes from a “b” rating to a “c+” rating in a research report on Tuesday, June 4th. Finally, Zacks Investment Research raised FirstService from a “strong sell” rating to a “hold” rating and set a $110.00 price target on the stock in a research report on Tuesday, June 25th. Five research analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus price target of $55.60.

NYSE FUL traded down $0.12 during trading on Friday, reaching $47.96. 370,795 shares of the company’s stock were exchanged, compared to its average volume of 357,628. The firm’s 50 day simple moving average is $44.89. The firm has a market capitalization of $2.45 billion, a PE ratio of 15.99, a P/E/G ratio of 1.31 and a beta of 1.59. The company has a quick ratio of 1.40, a current ratio of 2.14 and a debt-to-equity ratio of 1.85. HB Fuller has a fifty-two week low of $39.22 and a fifty-two week high of $59.58.

HB Fuller (NYSE:FUL) last announced its quarterly earnings results on Wednesday, June 26th. The specialty chemicals company reported $0.88 earnings per share for the quarter, missing analysts’ consensus estimates of $0.89 by ($0.01). HB Fuller had a return on equity of 13.38% and a net margin of 4.31%. The business had revenue of $759.60 million for the quarter, compared to analyst estimates of $779.07 million. During the same period last year, the firm earned $0.89 EPS. HB Fuller’s quarterly revenue was down 3.8% compared to the same quarter last year. On average, analysts forecast that HB Fuller will post 3.16 earnings per share for the current year.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Icon Wealth Partners LLC bought a new stake in HB Fuller during the first quarter worth $27,000. Investors Research Corp bought a new stake in HB Fuller during the first quarter worth $58,000. Advisor Group Inc. lifted its stake in shares of HB Fuller by 52.8% in the 4th quarter. Advisor Group Inc. now owns 1,497 shares of the specialty chemicals company’s stock valued at $64,000 after acquiring an additional 517 shares during the last quarter. Strs Ohio lifted its stake in shares of HB Fuller by 92.3% in the 1st quarter. Strs Ohio now owns 2,500 shares of the specialty chemicals company’s stock valued at $121,000 after acquiring an additional 1,200 shares during the last quarter. Finally, BerganKDV Wealth Management LLC bought a new position in shares of HB Fuller in the 1st quarter valued at $146,000. Hedge funds and other institutional investors own 98.86% of the company’s stock.

HB Fuller Company Profile

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, and other specialty chemical products worldwide. The company operates through five segments: Americas Adhesives, EIMEA, Asia Pacific, Construction Adhesives, and Engineering Adhesives.

Featured Article: What does an outperform rating mean?

Receive News & Ratings for HB Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HB Fuller and related companies with MarketBeat.com's FREE daily email newsletter.